Related Experiment Video
Updated: May 13, 2025

07:34
Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
Published on: December 15, 2023
1.7K
MK5 Regulates Microglial Activation and Neuroinflammation in Experimental Stroke Models
Xingzhi Wang1,2, Wenqi Mao1,2,3, Li Du1,2
1Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
CNS Neuroscience & Therapeutics
|April 16, 2025
Summary
Microglial MK5 is essential for mitigating neuroinflammation after ischemic stroke. Its absence worsens stroke outcomes by increasing inflammation and microglial activation.
Area of Science:
- Neuroscience
- Immunology
- Molecular Biology
Background:
- Microglial activation is central to neuroinflammation following ischemic stroke.
- Understanding the molecular mechanisms governing microglial responses is crucial for developing effective stroke therapies.
Purpose of the Study:
- To investigate the role of MK5 in microglial cells during the inflammatory response to ischemic stroke.
- To elucidate the potential mechanisms underlying MK5's function in neuroinflammation.
Main Methods:
- Utilized microglia-specific conditional MK5 knockout (MK5 cKO) mice and BV2 microglial cells.
- Induced ischemic conditions using middle cerebral artery occlusion (MCAO) in vivo and oxygen-glucose deprivation/reperfusion (OGD/R) in vitro.
- Assessed neurological deficits, infarct volume, inflammatory markers, microglial activation, and protein phosphorylation (HSP27, NF-κB).
Main Results:
- MK5 knockout exacerbated neurological deficits and infarct volume in MCAO mice.
- Loss of MK5 enhanced pro-inflammatory responses and microglial activation in both in vivo and in vitro models.
- MK5 deficiency reduced HSP27 phosphorylation and increased NF-κB phosphorylation.
Conclusions:
- Microglial MK5 plays a critical role in regulating the ischemic neuroinflammatory response.
- MK5 influences neuroinflammation by modulating HSP27 and NF-κB phosphorylation.
- MK5 represents a potential therapeutic target for treating ischemic stroke.

